H.-J. Senn

University of St.Gallen — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index5.7kcitations80works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(25), Cancer Treatment and Pharmacology(14), HER2/EGFR in Cancer Research(9), Colorectal Cancer Treatments and Studies(6), Estrogen and related hormone effects(5)

Publications80 total

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
Annals of Oncology·2021· 756 citedOpen Access
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
Annals of Oncology·2019· 670 citedOpen Access
Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Annals of Oncology·2018· 55 citedOpen Access
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Annals of Oncology·2015· 1.8k citedOpen Access
Adjuvant Chemoimmunotherapy with LMF + BCG in Node-Negative and Node-Positive Breast Cancer Patients1
Antibiotics and chemotherapy/Antibiotica et chemotherapia·2015· 9 cited
Estimates of benefits and harms of prophylactic use of aspirin in the general population
Annals of Oncology·2014· 382 citedOpen Access
Chemoprevention of breast and prostate cancers: where do we stand?
Annals of Oncology·2008· 8 citedOpen Access
Osteosynthese bei metastatischem Skelettbefall des Mammakarzinoms: Subjektiver und objektiver Gewinn
DMW - Deutsche Medizinische Wochenschrift·2008
Leukämien bei chemotherapierten Tumorpatienten
DMW - Deutsche Medizinische Wochenschrift·2008· 1 cited
First—select the target: better choice of adjuvant treatments for breast cancer patients
Annals of Oncology·2006· 99 citedOpen Access
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
Annals of Oncology·2006· 86 citedOpen Access
Multitarget stereotactic core-needle breast biopsy (MSBB)—an effective and safe diagnostic intervention for non-palpable breast lesions: A large prospective single institution study
The Breast·2006· 8 cited
Response to comments on “The process of metastasisation for breast cancer” by J. Engel, R. Eckel, J. Kerr et al.
European Journal of Cancer·2004· 8 cited
Krebs im Alter – eine wachsende Herausforderung. Studienkonzepte und Therapieoptionen für ältere Tumorpatienten
Oncology Research and Treatment·2004Open Access
Adjuvante Brustkrebstherapie in der Postmenopause: Anastrozol und Fulvestrant bringen Fortschritt
Oncology Research and Treatment·2004Open Access
Table of Contents · Inhaltsverzeichnis
Oncology Research and Treatment·2004· 1 cited
EGFR-Blockade. Neue Therapieoption für solide Tumoren
Oncology Research and Treatment·2004· 1 citedOpen Access
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer
The Breast·2003· 41 citedOpen Access
The process of metastasisation for breast cancer
European Journal of Cancer·2003· 159 cited
Multitarget stereotactic breast biopsy — A short and safe diagnostic intervention for non-palpable breast-lesions
The Breast·2003Open Access
page 1 of 4Next →

Frequent Co-authors

Beat Thürlimann(9), Aron Goldhirsch(8), Alan S. Coates(7), Eric P. Winer(6), Richard D. Gelber(6), Michael Gnant(6), Giuseppe Curigliano(5), Martine Piccart(4), Harold J. Burstein(4), Meredith M. Regan(4), R. Morant(4), W. F. Jungi(4), Fabrice André(3), Jonas Bergh(3), Hervé Bonnefoi(3), Fátima Cardoso(3), Marco Colleoni(3), Bent Ejlertsen(3), Nadia Harbeck(3), Zefei Jiang(3)